In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 39093-93-1, name is Thiomorpholine 1,1-dioxide, introducing its new discovery. SDS of cas: 39093-93-1
Synthetic method JAKAK1 inhibitor Filgogogotinib (by machine translation)
The invention provides Filgogogotinib, which comprises the following steps: (1) reacting 2 – amino -6 -bromopyridine with p-methylbenzene derivatives, and preparing compound 1; (2) reacting compound 1 with hydroxylamine hydrochloride, N, N – diisopropylethylamine to obtain compound 2; (3) reacting compound 2 with thiomorpholine 3, 4 dioxides, thereby obtaining Filgogogotinib.) . compound (3) and compound (4) are reacted, yielding compound 5, compound [4], and azodiisobutyronitrile to react, and the compound 5; (6 1 -) 5 is reacted with the azodiisobutyronitrile -1. The route of synthesizing Filgogogou is firstly coupled and then closed loop, the raw material is cheap, the reaction operation is simple, the product is easy to purify, the yield is high, and the method is suitable for commercial scale production. (by machine translation)
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 39093-93-1, and how the biochemistry of the body works.SDS of cas: 39093-93-1
Reference£º
Thiomorpholine – Wikipedia,
Thiomorpholine | C4H9NS – PubChem